Urethral bulking injections

Urethral bulking injections are a minimally invasive treatment option for urinary incontinence, particularly stress urinary incontinence (SUI). This condition primarily affects women, especially those who have experienced childbirth, menopause, or other factors that weaken the pelvic floor muscles. The procedure aims to improve the function of the urethral sphincter by increasing its size and allowing it to close more effectively, thereby preventing involuntary urine leakage.

Procedure

Urethral bulking injections involve the transurethral injection of bulking agents into the urethral wall. The procedure is typically performed under local anesthesia and may be done in an outpatient setting. Using cystoscopy for guidance, the physician injects a bulking agent, such as polydimethylsiloxane (silicone), calcium hydroxylapatite, or a biodegradable material, into the submucosal layer of the urethra near the bladder neck. The goal is to create a coaptation zone that helps the urethra close more effectively, thus preventing leaks.

Indications

Urethral bulking injections are indicated for patients with stress urinary incontinence, particularly those who:

• Prefer a minimally invasive option
• Have not responded adequately to pelvic floor muscle training or other conservative treatments
• Are not candidates for more invasive surgical procedures, such as sling procedures or urethropexy
• Wish to avoid or are not suitable for general anesthesia

Advantages and Disadvantages

Advantages

• Minimally invasive with a quick recovery time
• Performed under local anesthesia
• Can be repeated if necessary
• Suitable for patients who are not candidates for surgery

Disadvantages

• May require multiple sessions to achieve desired results
• Less durable than some surgical options
• Risk of migration or absorption of the bulking agent over time, necessitating repeat injections

Risks and Complications

While generally safe, urethral bulking injections can have complications, including:

• Urinary tract infections
• Urinary retention
• Hematuria (blood in the urine)
• Migration of the bulking agent
• Allergic reactions to the bulking material

Outcomes

Studies have shown that urethral bulking injections can effectively reduce symptoms of stress urinary incontinence in the short to medium term. However, the durability of the treatment varies, and some patients may require repeat injections to maintain continence.

Conclusion

Urethral bulking injections offer a minimally invasive treatment option for stress urinary incontinence, with the potential for symptom improvement in suitable candidates. Patients should discuss the benefits and risks with their healthcare provider to determine if this treatment is appropriate for their condition.

Resources

Latest articles - Urethral bulking injections

• Most recent articles
• Ongoing trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Urethral bulking injections for any updates.

‎